Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THRIVE: Thiamine in Infants with Meningitis or Bacteremia
NCT07868679Phase 2Not yet recruiting
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Dec 2026
- Primary completion
- Nov 2031
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in meningitis and Bacteremia comparing Thiamine with Placebo (2 arms). Primary endpoint: Cognitive Neurodevelopment. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
thiamine
03
Conditions
meningitisBacteremia
Beyond the preview
Go deeper on NCT07868679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07868679.